Global Engage is pleased to announce its 2nd Microbiome R&D and Business Collaboration Congress: Asia which will be held on 29 February - 1 March, 2016, in Kuala Lumpur, Malaysia.
With increasing signs that our microbiome may be the key not only for curative but preventative medicine, efforts are focusing on increasing investment opportunities, clinical trials and innovative research in this area. With an increasing focus on healthy living and a therapeutics market that is expected to grow to $1.2 trillion by 2016, microbiome research can be developed in order to provide preventative treatments, cures, therapies and supplements for a worldwide audience in demand.
The 2-day congress will examine a range of topics including: